A Population-based Study on the First Forty-Eight Breast Cancer Patients Receiving Trastuzumab (Herceptin®) on a Named Patient Basis in Sweden-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A Population-based Study on the First Forty-Eight Breast Cancer Patients Receiving Trastuzumab (Herceptin®) on a Named Patient Basis in Sweden

Published:2002-01 Issue:3 Volume:41 Page:276-281
ISSN:0284-186X
Container-title:Acta Oncologica
language:en
Short-container-title:Acta Oncologica

Author:

Andersson Jenny,Linderholm Barbro,Greim Gudrun,Lindh Birgitta,Lindman Henrik,Tennvall Jan,Tennvall-Nittby Lena,Pettersson-Sköld Dagny,Sverrisdottir Asgerdur,Söderberg Martin,Klaar Sigrid,Bergh Jonas

Publisher

Informa UK Limited

Subject

Radiology, Nuclear Medicine and imaging,Oncology,Hematology,General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.1080/02841860260088827

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. How iMALDI can improve clinical diagnostics;The Analyst;2018

2. Use of trastuzumab for HER2-positive metastatic breast cancer in daily practice;Anti-Cancer Drugs;2016-02

3. Trastuzumab;Meyler's Side Effects of Drugs;2016

4. MiR-221 promotes trastuzumab-resistance and metastasis in HER2-positive breast cancers by targeting PTEN;BMB Reports;2014-05-31

5. Positive spillover effects of prescribing requirements: increased cardiac testing in patients treated with trastuzumab for HER2+ metastatic breast cancer;Internal Medicine Journal;2012-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP